ReVIDA Recovery Centers, LLC: Comprehensive Company Profile

Background

Mission and Vision

ReVIDA Recovery Centers, LLC is dedicated to promoting safe and healthy communities by empowering individuals to reclaim their lives from opioid use disorder. The company envisions developing a premier network of outpatient recovery centers that deliver clinical excellence and industry-leading outcomes.

Primary Area of Focus and Industry Significance

Specializing in the treatment of opioid use disorder, ReVIDA Recovery Centers operates in the behavioral healthcare industry, offering comprehensive services that integrate Medication Assisted Treatment (MAT) to address the multifaceted challenges of addiction. The company plays a significant role in combating the opioid epidemic, particularly in regions severely affected by high overdose rates.

Key Strategic Focus

Core Objectives

ReVIDA Recovery Centers aims to provide holistic care that addresses the physical, emotional, and social aspects of recovery, ensuring sustainable outcomes for individuals battling opioid addiction.

Specific Areas of Specialization

The company specializes in outpatient recovery services, utilizing evidence-based practices to treat opioid use disorder. Their approach emphasizes personalized treatment plans, integrating MAT with counseling and support services.

Key Technologies Utilized

ReVIDA employs modern digital tools, including Tableau for data analysis and LiveChat for patient engagement, to enhance service delivery and operational efficiency.

Primary Markets Targeted

The company primarily serves communities in Middle and East Tennessee, as well as Southwest Virginia, regions significantly impacted by the opioid crisis.

Financials and Funding

Funding History and Financial Performance

As of 2025, ReVIDA Recovery Centers is estimated to generate annual revenue between $25 million and $50 million, indicating a robust financial position within the behavioral healthcare sector.

Recent Funding Rounds and Notable Investors

Specific details regarding recent funding rounds and investors are not publicly disclosed.

Utilization of Capital

While exact allocations are not specified, the capital is likely directed towards expanding treatment facilities, enhancing service offerings, and integrating advanced technologies to improve patient care and operational efficiency.

Pipeline Development

Key Pipeline Candidates and Development Stages

ReVIDA Recovery Centers focuses on expanding its network of outpatient recovery centers, with recent openings in Fayetteville, North Carolina, and Chattanooga, Tennessee, to increase access to opioid use disorder treatment.

Target Conditions and Relevant Timelines

The primary target condition is opioid use disorder. The company continues to assess and address the evolving needs of the communities it serves, with ongoing efforts to expand and enhance treatment services.

Technological Platform and Innovation

Proprietary Technologies

ReVIDA utilizes proprietary methodologies in its MAT programs, integrating counseling and support services to provide comprehensive care.

Significant Scientific Methods

The company employs evidence-based practices, combining MAT with counseling and support services to address the multifaceted challenges of opioid addiction.

Leadership Team

Executive Profiles

Lee Dilworth: President & Chief Executive Officer. With extensive experience in healthcare business and legal affairs, Dilworth is dedicated to patient care, clinical excellence, and regulatory compliance.

Greg Phillips: Chief Operating Officer. Phillips brings operational expertise to oversee the company's daily functions and strategic initiatives.

Evan Norton: Chief Financial Officer. Norton manages the company's financial strategies and operations, ensuring fiscal responsibility and growth.

Lindsay Key, LPC-MHSP: Chief Revenue Officer / Chief Clinical Officer. Key oversees clinical operations and revenue strategies, integrating clinical excellence with financial performance.

Susan Gilman, LCSW: Clinical Director. Gilman leads clinical services, ensuring the delivery of high-quality, evidence-based treatment programs.

Board of Directors

Marty Rash: Chairman. Rash has a background in healthcare leadership, contributing strategic direction to the company.

Byron Smith: Board Member. Smith offers expertise in venture capital and healthcare services, guiding the company's growth initiatives.

Dave Cooley: Board Member. Cooley brings experience in public service and healthcare public affairs, advising on policy and community relations.

Gabe Roberts: Board Member. Roberts, former CEO of TennCare, provides insights into healthcare management and policy.

Competitor Profile

Market Insights and Dynamics

The behavioral healthcare industry, particularly in the realm of opioid use disorder treatment, is experiencing significant growth due to the ongoing opioid epidemic. There is an increasing demand for comprehensive outpatient recovery services, presenting opportunities for expansion and innovation.

Competitor Analysis

Key competitors include:

Community Medical Services: With an estimated revenue of $177.2 million and 525 employees, they offer a range of addiction treatment services.

Solace Healthcare: Generating approximately $126.6 million in revenue and employing 375 individuals, they provide comprehensive behavioral health services.

Infusion Express: With around $16 million in revenue and 66 employees, they focus on outpatient infusion therapy services.

Strategic Collaborations and Partnerships

ReVIDA collaborates with various community organizations, including the Sullivan County Anti-Drug Coalition, to administer Naloxone kits and support overdose prevention efforts.

Operational Insights

ReVIDA's focus on outpatient services and community partnerships differentiates it from competitors by emphasizing localized, accessible care and community engagement.

Strategic Opportunities and Future Directions

Strategic Roadmap

ReVIDA plans to continue expanding its network of outpatient recovery centers, enhancing service offerings, and integrating advanced technologies to improve patient care and operational efficiency.

Opportunities for Expansion

The company is exploring opportunities to enter new markets, particularly in regions with high rates of opioid use disorder, to extend its impact and services.

Future Objectives

ReVIDA aims to set the standard for outpatient recovery services, focusing on clinical excellence, patient-centered care, and community collaboration to achieve sustainable outcomes.